These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8542002)

  • 21. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population.
    El Saleeby CM; Li R; Somes GW; Dahmer MK; Quasney MW; DeVincenzo JP
    J Pediatr; 2010 Mar; 156(3):409-14. PubMed ID: 19914637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus.
    Ferrero F; Lin CY; Liese J; Luz K; Stoeva T; Nemeth A; Gijón M; Calvo C; Natalini S; Toh TH; Deleu S; Chen B; Rusch S; Sánchez BL; Leipoldt I; Vijgen L; Huntjens D; Baguet T; Bertzos K; Gamil M; Stevens M;
    Paediatr Drugs; 2024 Jul; 26(4):411-427. PubMed ID: 38649595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of characteristics and outcomes in severe human metapneumovirus and respiratory syncytial virus infections in children treated in an intensive care unit.
    Eggleston HA; Gunville CF; Miller JI; Sontag MK; Mourani PM
    Pediatr Infect Dis J; 2013 Dec; 32(12):1330-4. PubMed ID: 23811741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
    O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
    Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practices. The Pediatric Investigators Collaborative Network on Infections in Canada.
    Law BJ; De Carvalho V
    Pediatr Infect Dis J; 1993 Aug; 12(8):659-63. PubMed ID: 8414779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.
    Somers CC; Ahmad N; Mejias A; Buckingham SC; Carubelli C; Katz K; Leos N; Gomez AM; DeVincenzo JP; Ramilo O; Jafri HS
    Pediatr Allergy Immunol; 2009 Aug; 20(5):477-85. PubMed ID: 19397752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth.
    Villamor E; Mbise R; Spiegelman D; Hertzmark E; Fataki M; Peterson KE; Ndossi G; Fawzi WW
    Pediatrics; 2002 Jan; 109(1):E6. PubMed ID: 11773574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections.
    Kjolhede CL; Chew FJ; Gadomski AM; Marroquin DP
    J Pediatr; 1995 May; 126(5 Pt 1):807-12. PubMed ID: 7752011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence and severity of pertussis in infants with a respiratory syncytial virus infection].
    Moreno Samos M; Amores Torres M; Pradillo Martín MC; Moreno-Pérez D; Cordón Martínez A; Urda Cardona A; Ramos Fernández JM
    Enferm Infecc Microbiol Clin; 2015; 33(7):476-9. PubMed ID: 25459193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of vitamin A in children with severe measles.
    Hussey GD; Klein M
    N Engl J Med; 1990 Jul; 323(3):160-4. PubMed ID: 2194128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR; Wilson JW; Razonable RR;
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.
    Sáez-Llorens X; Moreno MT; Ramilo O; Sánchez PJ; Top FH; Connor EM;
    Pediatr Infect Dis J; 2004 Aug; 23(8):707-12. PubMed ID: 15295219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
    Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G
    PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants.
    Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E
    Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial.
    van Woensel JB; Vyas H;
    Crit Care Med; 2011 Jul; 39(7):1779-83. PubMed ID: 21460709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Children hospitalized with respiratory syncytial virus infection in Saskatchewan pediatric tertiary care centers, 2002-2005.
    Kurji A; Tan B; Bodani J; Janzen B; McConnell A; Bodani R; Rajakumar D; Sharma A; Sankaran K
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1005-13. PubMed ID: 25344181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.